Cell Cycle Gene Alterations Associate with a Redistribution of Mutation Risk Across Chromosomal Domains in Human Cancers

Overview

Journal Nat Cancer

Specialty Oncology

Date 2024 Jan 10

PMID 38200245

Authors

Marina Salvadores

Fran Supek

Affiliations

Soon will be listed here.

Abstract

Mutations in human cells exhibit increased burden in heterochromatic, late DNA replication time (RT) chromosomal domains, with variation in mutation rates between tissues mirroring variation in heterochromatin and RT. We observed that regional mutation risk further varies between individual tumors in a manner independent of cell type, identifying three signatures of domain-scale mutagenesis in >4,000 tumor genomes. The major signature reflects remodeling of heterochromatin and of the RT program domains seen across tumors, tissues and cultured cells, and is robustly linked with higher expression of cell proliferation genes. Regional mutagenesis is associated with loss of activity of the tumor-suppressor genes RB1 and TP53, consistent with their roles in cell cycle control, with distinct mutational patterns generated by the two genes. Loss of regional heterogeneity in mutagenesis is associated with deficiencies in various DNA repair pathways. These mutation risk redistribution processes modify the mutation supply towards important genes, diverting the course of somatic evolution.

Citing Articles

The significance of in multiple myeloma.

Wang Y, Yang R, Liu R, Yang R, Lin Z, He A Front Immunol. 2024; 15():1415972.

PMID: 39664374 PMC: 11631746. DOI: 10.3389/fimmu.2024.1415972.

Fantastic Frogs and Where to Use Them: Unveiling the Hidden Cinobufagin's Promise in Combating Lung Cancer Development and Progression Through a Systematic Review of Preclinical Evidence.

Barbalho S, Pomini K, de Lima E, da Silva Camarinha Oliveira J, Leme Boaro B, Cressoni Araujo A Cancers (Basel). 2024; 16(22).

PMID: 39594713 PMC: 11592936. DOI: 10.3390/cancers16223758.

Advances in predicting breast cancer driver mutations: Tools for precision oncology (Review).

Hao W, Rajendran B, Cui T, Sun J, Zhao Y, Palaniyandi T Int J Mol Med. 2024; 55(1).

PMID: 39450552 PMC: 11537269. DOI: 10.3892/ijmm.2024.5447.

Inferring replication timing and proliferation dynamics from single-cell DNA sequencing data.

Weiner A, Williams M, Shi H, Vazquez-Garcia I, Salehi S, Rusk N Nat Commun. 2024; 15(1):8512.

PMID: 39353885 PMC: 11445576. DOI: 10.1038/s41467-024-52544-7.

Copy number losses of oncogenes and gains of tumor suppressor genes generate common driver mutations.

Besedina E, Supek F Nat Commun. 2024; 15(1):6139.

PMID: 39033140 PMC: 11271286. DOI: 10.1038/s41467-024-50552-1.

References

Supek F, Lehner B . Differential DNA mismatch repair underlies mutation rate variation across the human genome. Nature. 2015; 521(7550):81-4. PMC: 4425546. DOI: 10.1038/nature14173. View

Zheng C, Wang N, Chung J, Moslehi H, Sanborn J, Hur J . Transcription restores DNA repair to heterochromatin, determining regional mutation rates in cancer genomes. Cell Rep. 2014; 9(4):1228-34. PMC: 4254608. DOI: 10.1016/j.celrep.2014.10.031. View

Pope B, Ryba T, Dileep V, Yue F, Wu W, Denas O . Topologically associating domains are stable units of replication-timing regulation. Nature. 2014; 515(7527):402-5. PMC: 4251741. DOI: 10.1038/nature13986. View

Akdemir K, Le V, Kim J, Killcoyne S, King D, Lin Y . Somatic mutation distributions in cancer genomes vary with three-dimensional chromatin structure. Nat Genet. 2020; 52(11):1178-1188. PMC: 8350746. DOI: 10.1038/s41588-020-0708-0. View

Hansen R, Thomas S, Sandstrom R, Canfield T, Thurman R, Weaver M . Sequencing newly replicated DNA reveals widespread plasticity in human replication timing. Proc Natl Acad Sci U S A. 2009; 107(1):139-44. PMC: 2806781. DOI: 10.1073/pnas.0912402107. View

Polak P, Karlic R, Koren A, Thurman R, Sandstrom R, Lawrence M . Cell-of-origin chromatin organization shapes the mutational landscape of cancer. Nature. 2015; 518(7539):360-364. PMC: 4405175. DOI: 10.1038/nature14221. View

Makova K, Hardison R . The effects of chromatin organization on variation in mutation rates in the genome. Nat Rev Genet. 2015; 16(4):213-23. PMC: 4500049. DOI: 10.1038/nrg3890. View

Schuster-Bockler B, Lehner B . Chromatin organization is a major influence on regional mutation rates in human cancer cells. Nature. 2012; 488(7412):504-7. DOI: 10.1038/nature11273. View

Salvadores M, Mas-Ponte D, Supek F . Passenger mutations accurately classify human tumors. PLoS Comput Biol. 2019; 15(4):e1006953. PMC: 6483366. DOI: 10.1371/journal.pcbi.1006953. View

10.

Koren A, Handsaker R, Kamitaki N, Karlic R, Ghosh S, Polak P . Genetic variation in human DNA replication timing. Cell. 2014; 159(5):1015-1026. PMC: 4359889. DOI: 10.1016/j.cell.2014.10.025. View

11.

McRae A, Marioni R, Shah S, Yang J, Powell J, Harris S . Identification of 55,000 Replicated DNA Methylation QTL. Sci Rep. 2018; 8(1):17605. PMC: 6279736. DOI: 10.1038/s41598-018-35871-w. View

12.

Oliva M, Demanelis K, Lu Y, Chernoff M, Jasmine F, Ahsan H . DNA methylation QTL mapping across diverse human tissues provides molecular links between genetic variation and complex traits. Nat Genet. 2022; 55(1):112-122. PMC: 10249665. DOI: 10.1038/s41588-022-01248-z. View

13.

Gate R, Cheng C, Aiden A, Siba A, Tabaka M, Lituiev D . Genetic determinants of co-accessible chromatin regions in activated T cells across humans. Nat Genet. 2018; 50(8):1140-1150. PMC: 6097927. DOI: 10.1038/s41588-018-0156-2. View

14.

Kinker G, Greenwald A, Tal R, Orlova Z, Cuoco M, McFarland J . Pan-cancer single-cell RNA-seq identifies recurring programs of cellular heterogeneity. Nat Genet. 2020; 52(11):1208-1218. PMC: 8135089. DOI: 10.1038/s41588-020-00726-6. View

15.

Barkley D, Moncada R, Pour M, Liberman D, Dryg I, Werba G . Cancer cell states recur across tumor types and form specific interactions with the tumor microenvironment. Nat Genet. 2022; 54(8):1192-1201. PMC: 9886402. DOI: 10.1038/s41588-022-01141-9. View

16.

Du Q, Bert S, Armstrong N, Caldon C, Song J, Nair S . Replication timing and epigenome remodelling are associated with the nature of chromosomal rearrangements in cancer. Nat Commun. 2019; 10(1):416. PMC: 6345877. DOI: 10.1038/s41467-019-08302-1. View

17.

Du Q, Smith G, Luu P, Ferguson J, Armstrong N, Caldon C . DNA methylation is required to maintain both DNA replication timing precision and 3D genome organization integrity. Cell Rep. 2021; 36(12):109722. DOI: 10.1016/j.celrep.2021.109722. View

18.

Zhou W, Dinh H, Ramjan Z, Weisenberger D, Nicolet C, Shen H . DNA methylation loss in late-replicating domains is linked to mitotic cell division. Nat Genet. 2018; 50(4):591-602. PMC: 5893360. DOI: 10.1038/s41588-018-0073-4. View

19.

Brinkman A, Nik-Zainal S, Simmer F, Rodriguez-Gonzalez F, Smid M, Alexandrov L . Partially methylated domains are hypervariable in breast cancer and fuel widespread CpG island hypermethylation. Nat Commun. 2019; 10(1):1749. PMC: 6465362. DOI: 10.1038/s41467-019-09828-0. View

20.

Gurrion C, Uriostegui M, Zurita M . Heterochromatin Reduction Correlates with the Increase of the KDM4B and KDM6A Demethylases and the Expression of Pericentromeric DNA during the Acquisition of a Transformed Phenotype. J Cancer. 2017; 8(14):2866-2875. PMC: 5604219. DOI: 10.7150/jca.19477. View